title: Emphysematous gastritis associated with ulcerative esophagitis.
abstract: Emphysematous gastritis is a rare form of gastritis characterized by gaseous dissection of the stomach wall usually secondary to invasion by gas forming organisms, corrosive ingestion, trauma, or gastric infarction. We report a unique case of emphysematous gastritis secondary to ulcerative esophagitis without an underlying history of trauma, ischemia, or ingestion of corrosive agents. The patient responded well to conservative management. Emphysematous gastritis is a deadly infectious disease. Early recognition and management are crucial as there is no specific approach to treatment despite advances in medical science.
authors.affiliation: Dayton Veterans Affairs Medical Center, Dayton, OH, USA.
authors.forename: S
authors.initials: S
authors.lastname: Hassan
authors.forename: K
authors.initials: K
authors.lastname: Abbass
authors.forename: R
authors.initials: R
authors.lastname: Markert
authors.forename: S
authors.initials: S
authors.lastname: Akram
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000150:complications; D002939:Ciprofloxacin / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004646:Emphysema / Q000150:complications*; D016145:Endoscopy, Digestive System; D004941:Esophagitis / Q000209:etiology*; D005756:Gastritis / Q000209:etiology*; D005764:Gastroesophageal Reflux / Q000150:complications; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D014456:Ulcer / Q000209:etiology*
chemical_list: D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors; D008795:Metronidazole; D002939:Ciprofloxacin